Biogen Idec (BIIB) – Bull of the Day
Source: http://www.zacks.com/commentary/11083/Biogen+Idec+%28BIIB%29+-+Bull+of+the+DayPosted on Wednesday, June 3rd, 2009 | In Market Commentary, Stocks to Watch
Biogen Idec (BIIB) posted solid results in the first quarter of 2009, despite the slowdown in Tysabri sales due to fears of PML. We think the Biogen core business will remain strong over the next several quarters. Tysabri prescriptions are showing an improvement and we believe will resume their previous pace shortly.
In the meantime, the name is significantly under-valued and would be a very attractive takeout
candidate for a large-cap pharmaceutical company looking for a great phase III pipeline. We expect 2009 to be an eventful year on the pipeline front.
As investors become more comfortable with both Tysabri trends and emerging pipeline, we believe shares will recover back into the low $60’s. At today’s price, the name is too attractive to ignore.Zacks Investment Research
Last 5 posts by Zacks Market Commentaries
- CNP & FPL Ink Pipeline Deal - Analyst Blog - November 20th, 2009
- Buffett Borrows for Rail Acquisition - Analyst Blog - November 20th, 2009
- Stone Energy Outdoes Estimates - Analyst Blog - November 20th, 2009
- Smucker's Beats, Raises Guidance - Analyst Blog - November 20th, 2009
- GameStop Meets Expectations - Analyst Blog - November 20th, 2009
Biogen Idec, large-cap pharmaceutical company looking;, Market Commentary, Stocks to Watch, Tysabri, USD, Zacks Market Commentaries
 About Zacks Market Commentaries (http://www.zacks.com/)
Zacks Market Commentaries |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.